| Literature DB >> 20628587 |
Yves Guichard1, Laurent Gaté, Christian Darne, Marie-Claire Bottin, Cristina Langlais, Jean-Claude Micillino, Michèle Goutet, Schmit Julien, Binet Stéphane.
Abstract
Asbestos-induced mutagenicity in the lung may involve reactive oxygen/nitrogen species (ROS/RNS) released by alveolar macrophages. With the aim of proposing an alternative in vitro mutagenesis test, a coculture system of rat alveolar macrophages (NR8383) and transgenic Big Blue Rat2 embryonic fibroblasts was developed and tested with a crocidolite sample. Crocidolite exposure induced no detectable increase in ROS production from NR8383, contrasting with the oxidative burst that occurred following a brief exposure (1 hour) to zymosan, a known macrophage activator. In separated cocultures, crocidolite and zymosan induced different changes in the gene expressions involved in cellular inflammation in NR8383 and Big Blue. In particular, both particles induced up-regulation of iNOS expression in Big Blue, suggesting the formation of potentially genotoxic nitrogen species. However, crocidolite exposure in separated or mixed cocultures induced no mutagenic effects whereas an increase in Big Blue mutants was detected after exposure to zymosan in mixed cocultures. NR8383 activation by crocidolite is probably insufficient to induce in vitro mutagenic events. The mutagenesis assay based on the coculture of NR8383 and Big Blue cannot be used as an alternative in vitro method to assess the mutagenic properties of asbestos fibres.Entities:
Year: 2010 PMID: 20628587 PMCID: PMC2901601 DOI: 10.1155/2010/323828
Source DB: PubMed Journal: J Toxicol ISSN: 1687-8191
Details of primer sets used.
| Primers | GenBank # | Sequences (5′–3′) | |
|---|---|---|---|
| TNF- | X66539 | Sense | AAA TGG GCT CCC TCT CAT CAG TTC |
| Antisense | TCT GCT TGG TGG TTT GCT ACG AC | ||
| IL1- | M98820 | Sense | CAC CTC TCA AGC AGA GCA CAG |
| Antisense | GGG TTC CAT GGT GAA GTC AAC | ||
| iNOS | L12562 | Sense | CAT TGG AAG TGA AGC GTT TCG |
| Antisense | CAG CTG GGC TGT ACA AAC CTT | ||
| IL6 | E02522 | Sense | TCC TAC CCC AAC TTC CAA TGC TC |
| Antisense | TTG GAT GGT CTT GGT CCT TAG CC | ||
| SOD2 | NM_017051 | Sense | TAAGGAGCAAGGTCGCTTACA |
| Antisense | TAAGGAGCAAGGTCGCTTACA | ||
|
| V01217 | Sense | AAG TCC CTC ACC CTC CCA AAA G |
| Antisense | AAG CAA TGC TGT CAC CTT CCC |
Figure 1Time course of oxidant production by NR8383 cells after incubation with crocidolite and zymosan. Oxidant production was measured as increased chemiluminescence of lucigenin (in relative light units, RLU). Each point represents the mean ± SD of three experiments. Control (∗); Crocidolite 15 μg/cm2 (□), 30 μg/cm2 (∆), and 60 μg/cm2 (∘); Zymosan 7.5 μg/cm2 (■), 15 μg/cm2 (▲), and 30 μg/cm2 (●).
Figure 2ROS production in NR8383 analysed by flow cytometry. NR8383 cells were preincubated with H2DCFDA (25 μm) for 30 minutes and then exposed to 10 μg/cm2 of crocidolite or zymosan for 3 hours. Representative histograms plot the relative green DCF fluorescence (FL1) within 15000 live cells (counts: numbers of events).
DCF fluorescence in particle-exposed NR8383 analysed by flow cytometry.
| Treatment | Mean fluorescence ± SD(1) |
|---|---|
| Control | 77.1 ± 5,9 |
| Crocidolite 1 | 71.5 ± 2,9 |
| Crocidolite 5 | 65.9 ± 13,5 |
| Crocidolite 10 | 65.7 ± 15,2 |
| Zymosan 10 | 236.5 ± 19,1* |
(1)Result obtained from three experiments.
*Statistically different from control values (P < .05).
Figure 3Effect of treatment with crocidolite and zymosan for 3 hours (15, 30, and 60 μg/cm2) or with crocidolite for 24 hours (3 and 15 μg/cm2) on the expression of various genes in NR8383-Big Blue separated cocultures. Levels of iNOS, IL1β, and TNFα mRNA in NR8383 and levels of iNOS, IL-6, and SOD-2 mRNA in Big Blue were assessed by qPCR, using β-actin as an endogenous external standard. Data are expressed as “fold change” of the control value (see materials and methods). Results represent the mean ± SD of at least 3 experiments. *Statistically significant (P < .05) increase in gene expression compared to the control (unexposed) cocultures.
Cytotoxicity and mutation frequencies in Big Blue cells following various treatments in mono- or coculture with NR8383 cells.
| Treatment and culture condition | % cell mortality (Mean ± SD) | PFU per assay | Mutant plaques | MF (×10−5) | Group average MF (×10−5± SD) | |
|---|---|---|---|---|---|---|
| ENU, monoculture, 30 min | Control | 1.2 ± 0.5 | 375000 | 32 | 8.5 | 9.6 ± 1.0 |
| 350000 | 36 | 10.3 | ||||
| 455000 | 46 | 10.1 | ||||
|
| ||||||
| 100 | 2.3 ± 1.4 | 285000 | 133 | 46.7 | 41.8 ± 8.7* | |
| 553333 | 176 | 31.8 | ||||
| 338330 | 159 | 47.0 | ||||
|
| ||||||
| 500 | 2.2 ± 0.5 | 223000 | 208 | 93.3 | 83.3 ± 9.8* | |
| 368330 | 306 | 83.1 | ||||
| 203666 | 150 | 73.6 | ||||
|
| ||||||
| Crocidolite separated coculture, 72 h | Control | 4.1 ± 1.9 (BB); 5.4 ±2.3 (NR) | 423334 | 47 | 11.1 | 12.9 ± 1.6 |
| 860333 | 102 | 11.9 | ||||
| 868333 | 122 | 14.0 | ||||
| 566667 | 79 | 13.9 | ||||
| 675000 | 79 | 11.7 | ||||
| 573333 | 86 | 15.0 | ||||
|
| ||||||
| 3 | 5.8 ± 2.0 (BB); 7.9 ±2.0 (NR) | 349000 | 25 | 7.2 | 8.7 ± 1.7 | |
| 477333 | 41 | 8.6 | ||||
| 506166 | 53 | 10.5 | ||||
|
| ||||||
| 15 | 3.6 ± 1.8 (BB); 19.6 ±1.3* (NR) | 1090000 | 127 | 11.7 | 13.2 ± 2.2 | |
| 786667 | 77 | 9.8 | ||||
| 445000 | 70 | 15.7 | ||||
| 723333 | 104 | 14.4 | ||||
| 567667 | 82 | 14.4 | ||||
| 616667 | 81 | 13.1 | ||||
|
| ||||||
| Crocidolite, mixed coculture, 24 h | Control | 8.2 ± 0.9 | 303350 | 63 | 20.8 | 19.0 ± 2.3 |
| 303350 | 57 | 18.8 | ||||
| 301650 | 68 | 22.5 | ||||
| 460000 | 79 | 17.2 | ||||
| 501650 | 83 | 16.5 | ||||
| 388350 | 71 | 18.3 | ||||
|
| ||||||
| 10 | 15.0 ± 1.4* | 246650 | 43 | 17.4 | 18.5 ± 4.4 | |
| 246650 | 63 | 25.5 | ||||
| 331650 | 71 | 21.4 | ||||
| 475333 | 61 | 12.8 | ||||
| 692333 | 122 | 17.6 | ||||
| 323350 | 52 | 16.1 | ||||
|
| ||||||
| Zymosan, mixed coculture, 3 h | Control | 7.1 ± 2.0 | 468333 | 69 | 14.7 | 13.0 ± 1.5 |
| 248000 | 30 | 12.1 | ||||
| 593333 | 72 | 12.1 | ||||
|
| ||||||
| 15 | 6.4 ± 0.8 | 525000 | 82 | 15.6 | 18.3 ± 2.9* | |
| 656667 | 118 | 18.0 | ||||
| 393334 | 84 | 21.4 | ||||
|
| ||||||
| 30 | 7.0 ± 0.9 | 471667 | 83 | 17.6 | 17.4 ± 1.4* | |
| 833334 | 156 | 18.7 | ||||
| 600000 | 96 | 16.0 | ||||
|
| ||||||
| 60 | 7.7 ± 1.8 | 465000 | 134 | 28.8 | 30.8 ± 7.0* | |
| 574167 | 144 | 25.1 | ||||
| 513333 | 198 | 38.6 | ||||
PFU: plaque forming unit; MF: mutant frequency; BB: Big Blue; NN: NR8383; *Statistically different from control values (P < .05).